Prevalence of ultrasound-detected residual synovitis and risk of relapse and structural progression in rheumatoid arthritis patients in clinical remission: a systematic review and meta-analysis
Open Access
- 13 June 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 53 (11) , 2110-2118
Abstract
Objectives. The aims of this study were to assess the prevalence of US-detected residual synovitis in patients with RA in clinical remission (CR) and evaluate its predictive value for relapse and structural progression. Methods. We performed a systematic literature search of Medline, Embase and rheumatology meeting databases from 1 January 2001 to 28 May 2012. The prevalence of US grey-scale (USGS) signals (synovial hypertrophy or joint effusion) and power Doppler (PD) signals were collected, taking into account CR definitions [44-joint DAS (DAS44), 28-joint DAS (DAS28), SDAI, ACR 1981 or ACR/European League Against Rheumatism 2011], stage of RA (early or long-standing) and US examination (from 5 to 44 joints assessed). A meta-analysis assessing the risk of relapse or structural progression in patients with synovitis involved the Mantel–Haenszel method. Results. We included 19 studies of 1618 patients, 1369 in remission. The prevalence of USGS positive (USGS+), USGS+/PD negative (PD−), USGS+/PD positive (PD+) and USGS negative (USGS−/PD− was 84%, 41%, 44% and 15%, respectively. The prevalence of USGS+ or USGS+/PD+ was comparable among CR definitions and US methods. The prevalence of USGS+ and USGS+/PD+ was greater for long-standing than early RA (P < 0.001). Meta-analyses of five studies (271 patients), three studies (173 patients) and two studies (798 joints) revealed an association of USGS+/PD+ and risk of relapse [odds ratio (OR) 3.2 (95% CI 1.8, 5.9), P = 0.0001, I2 = 0%] and structural progression in individual patients [OR 9.13 (95% CI 1.1, 74.3), P = 0.04, I2 = 43%] and joints [OR 6.95 (95% CI 3.4, 13.9), P < 0.0001, I2 = 6%] over 1–2 years. Conclusion. US-detected residual synovitis is frequent and predicts the risk of relapse and structural progression in RA patients with CR.Keywords
This publication has 32 references indexed in Scilit:
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateAnnals of the Rheumatic Diseases, 2014
- EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritisAnnals of the Rheumatic Diseases, 2013
- The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasoundAnnals of the Rheumatic Diseases, 2013
- Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohortAnnals of the Rheumatic Diseases, 2012
- The discrepancy between clinical and ultrasonographic remission in rheumatoid arthritis is not related to therapy or autoantibody statusRheumatology International, 2011
- A Systematic Literature Review Analysis of Ultrasound Joint Count and Scoring Systems to Assess Synovitis in Rheumatoid Arthritis According to the OMERACT FilterThe Journal of Rheumatology, 2011
- Recent concepts in the inhibition of radiographic progression with biologicsCurrent Opinion in Rheumatology, 2009
- Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: Predictive value in disease activity and radiologic progressionArthritis Care & Research, 2007
- Ultrasonography of the metatarsophalangeal joints in rheumatoid arthritis: Comparison with magnetic resonance imaging, conventional radiography, and clinical examinationArthritis & Rheumatism, 2004
- Arthritis of the finger joints: A comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imagingArthritis & Rheumatism, 1999